OA08815A - RNase L Inhibitor as a marker for virus infections. - Google Patents

RNase L Inhibitor as a marker for virus infections.

Info

Publication number
OA08815A
OA08815A OA59295A OA59295A OA08815A OA 08815 A OA08815 A OA 08815A OA 59295 A OA59295 A OA 59295A OA 59295 A OA59295 A OA 59295A OA 08815 A OA08815 A OA 08815A
Authority
OA
OAPI
Prior art keywords
rnase
marker
inhibitor
virus infections
infections
Prior art date
Application number
OA59295A
Other languages
English (en)
Inventor
William A Cartet
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of OA08815A publication Critical patent/OA08815A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
OA59295A 1987-12-23 1988-03-03 RNase L Inhibitor as a marker for virus infections. OA08815A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13697887A 1987-12-23 1987-12-23

Publications (1)

Publication Number Publication Date
OA08815A true OA08815A (en) 1989-03-31

Family

ID=22475294

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59295A OA08815A (en) 1987-12-23 1988-03-03 RNase L Inhibitor as a marker for virus infections.

Country Status (17)

Country Link
EP (1) EP0325018A3 (fr)
JP (1) JP2690493B2 (fr)
KR (1) KR890010562A (fr)
CN (1) CN1043569A (fr)
AU (2) AU1256488A (fr)
CA (1) CA1337277C (fr)
DK (1) DK112988A (fr)
FI (1) FI880960L (fr)
HU (1) HU205460B (fr)
IL (1) IL85577A0 (fr)
NO (1) NO880935L (fr)
OA (1) OA08815A (fr)
PH (1) PH25365A (fr)
PT (1) PT86880B (fr)
RU (1) RU1836101C (fr)
SU (1) SU1687035A3 (fr)
ZA (1) ZA881470B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278042A (en) * 1989-02-06 1994-01-11 The United States Of America As Represented By The Department Of Health & Human Services Method for detecting inhibitors of tat protein
FR2725214A1 (fr) * 1994-09-30 1996-04-05 Inst Nat Sante Rech Med Nouveaux composes utilisables pour la preparation d'agents anti-infectieux
US5985565A (en) 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
KR20010042069A (ko) 1998-03-20 2001-05-25 베니텍 오스트레일리아 리미티드 유전자 발현 조절방법
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP2314700A1 (fr) 1999-01-28 2011-04-27 Medical College of Georgia Research Institute, Inc Composition et méthode destinées à l'attenuation in vivo et in vitro de l'expression génique utilisant de l'ARN double brin
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US20020132257A1 (en) 2001-01-31 2002-09-19 Tony Giordano Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
CN112088903A (zh) * 2020-09-28 2020-12-18 武汉愔紫生物科技有限公司 一种大分子蛋白在抗菌抗病毒消毒剂中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505845A1 (fr) * 1981-05-13 1982-11-19 Choay Sa Procede de dosage de la 2',5'-oligo-adenylate-synthetase, methodes de detection d'une infection virale ou microbienne, de dosage de la concentration de l'interferon circulant ou present dans des tissus, apres administration de l'interferon, ou apres administration d'inducteurs de l'interferon et ensemble pret a l'emploi, ou kit, pour la mise en oeuvre desdits procedes de dosage et methodes de detection et de dosage
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (fr) * 1985-08-26 1994-01-25 William A. Carter Modulation des manifestations associees au virus du sida au moyen d'arn a double brin

Also Published As

Publication number Publication date
DK112988A (da) 1989-06-24
NO880935L (no) 1989-06-26
EP0325018A3 (fr) 1990-01-17
ZA881470B (en) 1988-11-18
CN1043569A (zh) 1990-07-04
KR890010562A (ko) 1989-08-09
AU660973B2 (en) 1995-07-13
DK112988D0 (da) 1988-03-02
HU205460B (en) 1992-04-28
FI880960A0 (fi) 1988-03-02
AU1618792A (en) 1992-09-10
PH25365A (en) 1991-05-13
EP0325018A2 (fr) 1989-07-26
NO880935D0 (no) 1988-03-02
JPH01171500A (ja) 1989-07-06
AU1256488A (en) 1989-06-29
CA1337277C (fr) 1995-10-10
JP2690493B2 (ja) 1997-12-10
PT86880B (pt) 1993-01-29
HUT47745A (en) 1989-03-28
PT86880A (pt) 1988-04-01
FI880960A7 (fi) 1989-06-24
SU1687035A3 (ru) 1991-10-23
IL85577A0 (en) 1988-08-31
FI880960L (fi) 1989-06-24
RU1836101C (ru) 1993-08-23

Similar Documents

Publication Publication Date Title
DE69012392D1 (de) Überweisungssystem.
EP0640096A4 (fr) Vaccin universel contre le coronavirus.
OA08815A (en) RNase L Inhibitor as a marker for virus infections.
GB2237475B (en) Image-transmission system for lightwave-transmitter-guided missile
DE68902543D1 (de) Pigmentverbundenes phosphor.
ZA904897B (en) Vip-analogs ii.
NO885498D0 (no) Kobling for sykkel.
DE3878802D1 (de) Konturenzeichner.
GB2204859B (en) Sleeve blank handling devices.
NO882679L (no) Merkestrimmelbaand.
FI903680A0 (fi) Bilhjul med gott faeste.
NO903446D0 (no) Gjenvinningssystem for oevelsetorpedo.
IE862774L (en) Darts.
NO884282D0 (no) Turret-koblinger ii.
DE3886264D1 (de) Elektronenstrahlerzeugersystem.
IE880586L (en) RNase L INHIBITOR AS MARKER FOR AIDS
ZA928396B (en) HIV protease inhibitors.
EP0285805A3 (en) New heptaene antibiotic, v-28-3m
IL83693A0 (en) Assay for virus infections
FI922430A7 (fi) Trefot foer skjutvapen.
NO890108D0 (no) Merkesystem.
IT89050810U1 (it) Forcella universale casework.
GB9002883D0 (en) Euro marker
AU99712S (en) T. shirt
GB8917416D0 (en) Masonry marker